Investor Carl Icahn aims to seat Richard Mulligan (second from right) and Alex Denner (far right) on Biogen Idec's board.
(Wendy Maeda/Globe Staff)
Biogen Idec counts the votes
One Icahn nominee is set to be seated, second is uncertain
Investor Carl Icahn aims to seat Richard Mulligan (second from right) and Alex Denner (far right) on Biogen Idec's board.
(Wendy Maeda/Globe Staff)
A day after adjourning its shareholders meeting without disclosing which candidates had won seats on its board, Biogen Idec Inc. conceded yesterday that investors probably had rebuked company executives and elected one of activist investor Carl C. Icahn's nominees. (Full article: 655 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
